Acuta Capital Partners’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-19,000
Closed -$266K 48
2024
Q3
$266K Buy
+19,000
New +$266K 0.22% 39
2016
Q3
Sell
-98,788
Closed -$1.76M 67
2016
Q2
$1.76M Sell
98,788
-101,212
-51% -$1.8M 0.85% 32
2016
Q1
$2.73M Sell
200,000
-170,000
-46% -$2.32M 1.53% 22
2015
Q4
$7.14M Buy
+370,000
New +$7.14M 3.41% 9